Close

Jaguar Animal Health (JAGX) Gains After Announcing Additional Topline Results from Study of Second-Gen. Formulation of Neonorm Calf

Go back to Jaguar Animal Health (JAGX) Gains After Announcing Additional Topline Results from Study of Second-Gen. Formulation of Neonorm Calf
(NASDAQ: JAGX) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $4.60 
Open $0.18    52 Week Low $0.81 
Day High $0.18    P/E N/A 
Day Low $0.18    EPS $0.00 
Volume 1,005,451